# Pre-emptive Treatments in Lupus Nephritis Patients With Serological Reactivation

> **NCT04870359** · NA · COMPLETED · sponsor: **The University of Hong Kong** · enrollment: 49 (actual)

## Conditions studied

- Lupus Nephritis

## Interventions

- **PROCEDURE:** Pre-emptive increase of immunosuppressive treatments
- **DRUG:** Prednisolone and/or AZA/MMF

## Key facts

- **NCT ID:** NCT04870359
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-21
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-03-31
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2024-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04870359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04870359, "Pre-emptive Treatments in Lupus Nephritis Patients With Serological Reactivation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04870359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*